7 research outputs found

    Evaluation of choice of medicine for hair growth in practising hair implant surgeons- original research

    No full text
    Aim The purpose of the present research was to assess the treatment effects of various pharmaceutical agents used by hair implant surgeons to induce hair growth in affected patients. Methodology this study, 500 patients we combined the use of anti­oxidants, iron, calcium, zinc, amino acids, and vitamins E, D, and C with minoxidil and finasteride to control hair loss, reverse miniaturization, and achieve new hair growth within 2-4 months with group I and II having male participants subjected to cyclic regimen and only minoxidil as well finasteride respectively whereas group II and IV had female participants also following cyclic as well as control regimen respectively. The patients were also followed clinically for 2 years and were observed to maintain their improvement. Results In Group I, the average improvement in density with cycli­cal medicine was 30% at 2 months and 52% at 4 months. The average improvement in caliber was 37% at 2 months and 47% at 4 months. In control Group II, density improved by an average of 2% at 2 months and 3.6% at 4 months. Caliber was unchanged in 44% of the patients.&nbsp

    Efficiency of prophylactic antibiotic coverage prior dental implant surgery: An original research

    No full text
    Purpose of the present study was to determine whether antibiotic prophylaxis is an effective and popular treatment aid in conjunction with oral implant placement in healthy patients. Observational cross-sectional study was conducted based on a web-survey reported according to the STROBE guidelines. A questionnaire was sent via email to each participant. It contained close-ended and some open-ended questions concerning demographics, antibiotic type, prescription duration and dosage which was analysed statistically using SPSS 25.0. Approximately 84% routinely prescribed prophylactic antibiotics in conjunction with oral implant surgery, 15.6% prescribed antibiotics in certain situations and only 1 did not prescribe antibiotics at all. Overall, 116 respondents prescribed both pre- and postoperative antibiotics, 29 prescribed antibiotics only preoperatively and 14 prescribed antibiotics exclusively after surgery. High range of prophylactic regimens is prescribed and they are not adhering to the new science-based specifications. Guidelines focused on the indications for prophylactic antibiotics among healthy patients are required to prevent bacterial resistance, side effects and costs caused by overtreatment and the irrational use of antibiotics

    Prevalence and determinants of frozen shoulder in patients with diabetes: An original research

    No full text
    Introduction: Adhesive capsulitis is a group of symptoms involving the glenohumeral joint which is a musculoskeletal problem that can affect the diabetics. The goal of this study is to determine the prevalence of FS and compare the disease's factors in a diabetic community. Materials and Methods: We piloted an observational cross-sectional study among 100 diabetics of both genders. The study was done for a period of 2 years, at a territary care center. We designed a questionnaire that collected the patients’ responses. These questions were formulated considering the important factors that may cause the Adhesive capsulitis among diabetics with an increased rate. Results: We observed that nearly 40% of the subject complained of the Adhesive capsulitis. The prevalence was at the department was 52.1%. The factors that were that were seen more associated among these cases of the Adhesive capsulitis were positive family history, uncontrolled blood glucose, insulin dependence and females. Greater number of the subjects had unilateral Adhesive capsulitis and was at stage 1 for the Adhesive capsulitis. Conclusion: Within the limitations of our study we observed a greater incidence of the Adhesive capsulitis among diabetics. This greater occurrence may be attributed to the poor glycemic control, lack of facilities, awareness, socio economic levels. Awareness camps are suggested to create education about these conditions targeting the female diabetics. Early intervention may alter the disease course and may favor a good prognosis. Further studies are suggested to find association of the diabetes and the Adhesive capsulitis

    Epidemiology and control of trachoma: systematic review.

    No full text
    Trachoma is the commonest infectious cause of blindness. Recurrent episodes of infection with serovars A-C of Chlamydia trachomatis cause conjunctival inflammation in children who go on to develop scarring and blindness as adults. It was estimated that in 2002 at least 1.3 million people were blind from trachoma, and currently 40 million people are thought to have active disease and 8.2 million to have trichiasis. The disease is largely found in poor, rural communities in developing countries, particularly in sub-Saharan Africa. The WHO promotes trachoma control through a multifaceted approach involving surgery, mass antibiotic distribution, encouraging facial cleanliness and environmental improvements. This has been associated with significant reductions in the prevalence of active disease over the past 20 years, but there remain a large number of people with trichiasis who are at risk of blindness

    Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.

    No full text
    BACKGROUND: Blinding trachoma, caused by ocular infection with Chlamydia trachomatis, is targeted for global elimination by 2020. Knowledge of risk factors can help target control interventions. METHODOLOGY/PRINCIPAL FINDINGS: As part of a cluster randomised controlled trial, we assessed the baseline prevalence of, and risk factors for, active trachoma and ocular C. trachomatis infection in randomly selected children aged 0-5 years from 48 Gambian and 36 Tanzanian communities. Both children's eyes were examined according to the World Health Organization (WHO) simplified grading system, and an ocular swab was taken from each child's right eye and processed by Amplicor polymerase chain reaction to test for the presence of C. trachomatis DNA. Prevalence of active trachoma was 6.7% (335/5033) in The Gambia and 32.3% (1008/3122) in Tanzania. The countries' corresponding Amplicor positive prevalences were 0.8% and 21.9%. After adjustment, risk factors for follicular trachoma (TF) in both countries were ocular or nasal discharge, a low level of household head education, and being aged ≥ 1 year. Additional risk factors in Tanzania were flies on the child's face, being Amplicor positive, and crowding (the number of children per household). The risk factors for being Amplicor positive in Tanzania were similar to those for TF, with the exclusion of flies and crowding. In The Gambia, only ocular discharge was associated with being Amplicor positive. CONCLUSIONS/SIGNIFICANCE: These results indicate that although the prevalence of active trachoma and Amplicor positives were very different between the two countries, the risk factors for active trachoma were similar but those for being Amplicor positive were different. The lack of an association between being Amplicor positive and TF in The Gambia highlights the poor correlation between the presence of trachoma clinical signs and evidence of C. trachomatis infection in this setting. Only ocular discharge was associated with evidence of C. trachomatis DNA in The Gambia, suggesting that at this low endemicity, this may be the most important risk factor. TRIAL REGISTRATION: ClinicalTrials.gov NCT00792922

    Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?

    No full text
    BACKGROUND: Trachoma has been endemic in The Gambia for decades. National trachoma control activities have been in place since the mid-1980's, but with no mass antibiotic treatment campaign. We aimed to assess the prevalence of active trachoma and of actual ocular Chlamydia trachomatis infection as measured by polymerase chain reaction (PCR) in the two Gambian regions that had had the highest prevalence of trachoma in the last national survey in 1996 prior to planned national mass antibiotic treatment distribution in 2006. METHODOLOGY/PRINCIPAL FINDINGS: Two stage random sampling survey in 61 randomly selected Enumeration Areas (EAs) in North Bank Region (NBR) and Lower River Region (LRR). Fifty randomly selected children aged under 10 years were examined per EA for clinical signs of trachoma. In LRR, swabs were taken to test for ocular C. trachomatis infection. Unadjusted prevalences of active trachoma were calculated, as would be done in a trachoma control programme. The prevalence of trachomatous inflammation, follicular (TF) in the 2777 children aged 1-9 years was 12.3% (95% CI 8.8%-17.0%) in LRR and 10.0% (95% CI 7.7%-13.0%) in NBR, with significant variation within divisions (p<0.01), and a design effect of 3.474. Infection with C. trachomatis was found in only 0.3% (3/940) of children in LRR. CONCLUSIONS/SIGNIFICANCE: This study shows a large discrepancy between the prevalence of trachoma clinical signs and ocular C. trachomatis infection in two Gambian regions. Assessment of trachoma based on clinical signs alone may lead to unnecessary treatment, since the prevalence of active trachoma remains high but C. trachomatis infection has all but disappeared. Assuming that repeated infection is required for progression to blinding sequelae, blinding trachoma is on course for elimination by 2020 in The Gambia
    corecore